CIK 0001818844 · Non-accelerated filer<br>Smaller reporting company
Dogwood Therapeutics, Inc.
Sign in to watch- Ticker
- DWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 854314201
- Phone
- 8666208655
- Business address
- 44 MILTON AVENUE, ALPHARETTA, GA, 30009
- Former names
- Virios Therapeutics, Inc., Virios Therapeutics, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-26 | Walsh Angela SVP OF FINANCE | Grant or award · Stock Option (right to buy) | +63,618 | 63,618 | ||
| 2024-02-26 | Grosswald Ralph SVP OF OPERATIONS | Grant or award · Stock Option (right to buy) | +62,568 | 62,568 | ||
| 2024-02-26 | Gendreau Roger Michael CHIEF MEDICAL OFFICER | Grant or award · Stock Option (right to buy) | +88,085 | 88,085 | ||
| 2024-02-26 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +138,835 | 138,835 | ||
| 2023-08-21 | Pridgen William Director | Purchase | +15,335 | $1.30 | $20K | 52,045 |
| 2023-08-17 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Purchase | +25,000 | $1.25 | $31K | 57,461 |
| 2023-06-15 | Keefer David R Director | Grant or award · Stock Option (right to buy) | +5,250 | 5,250 | ||
| 2023-06-15 | De La Rosa Abel Director | Grant or award · Stock Option (right to buy) | +5,250 | 5,250 | ||
| 2023-06-15 | Thomas John C Director | Grant or award · Stock Option (right to buy) | +5,250 | 5,250 | ||
| 2023-06-15 | Burch Richard Alan Director | Grant or award · Stock Option (right to buy) | +5,250 | 5,250 | ||
| 2023-06-15 | Whitley Richard James Director | Grant or award · Stock Option (right to buy) | +5,250 | 5,250 | ||
| 2023-06-15 | Pridgen William Director | Grant or award · Stock Option (right to buy) | +5,250 | 5,250 | ||
| 2022-12-12 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +410,000 | 410,000 | ||
| 2022-12-12 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +480,000 | 480,000 | ||
| 2022-12-12 | Walsh Angela SVP OF FINANCE | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2022-12-12 | Grosswald Ralph SVP OF OPERATIONS | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2022-12-12 | Gendreau Roger Michael CHIEF MEDICAL OFFICER | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2022-12-08 | Whitley Richard James Director | Sale | −1,800 | $0.26 | $466 | 700 |
| 2022-06-23 | Whitley Richard James Director | Grant or award · Stock Option (right to buy) | +5,250 | 5,250 | ||
| 2022-06-23 | Pridgen William Director | Grant or award · Stock Option (right to buy) | +5,250 | 5,250 |
Page 3 of 6 · 113 trades